Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2018 | 1 |
2020 | 1 |
2024 | 0 |
PubMed (GeneRIF) for id: 56978
4 results
Results by year
Filters applied: . Clear all
Page 1
PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation.
Clin Epigenetics. 2020 Aug 20;12(1):125. doi: 10.1186/s13148-020-00914-5.
Clin Epigenetics. 2020.
PMID: 32819411
Free PMC article.
PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1.
Chen Z, Gao W, Pu L, Zhang L, Han G, Zuo X, Zhang Y, Li X, Shen H, Wu J, Wang X.
Chen Z, et al.
Hepatology. 2018 Sep;68(3):994-1009. doi: 10.1002/hep.29890. Epub 2018 May 21.
Hepatology. 2018.
PMID: 29572888
Item in Clipboard
PRDM8 internal promoter hyperhydroxymethylation correlates with increased expression of the corresponding transcript in Down syndrome.
Lu Z, Liu Y, Ren Z, Yan J.
Lu Z, et al.
Mol Med Rep. 2016 Aug;14(2):1227-34. doi: 10.3892/mmr.2016.5375. Epub 2016 Jun 8.
Mol Med Rep. 2016.
PMID: 27278638
Item in Clipboard
DNA methylation in PRDM8 is indicative for dyskeratosis congenita.
Weidner CI, Lin Q, Birkhofer C, Gerstenmaier U, Kaifie A, Kirschner M, Bruns H, Balabanov S, Trummer A, Stockklausner C, Höchsmann B, Schrezenmeier H, Wlodarski M, Panse J, Brümmendorf TH, Beier F, Wagner W.
Weidner CI, et al.
Oncotarget. 2016 Mar 8;7(10):10765-72. doi: 10.18632/oncotarget.7458.
Oncotarget. 2016.
PMID: 26909595
Free PMC article.
Item in Clipboard
Cite
Cite